In clinical practice, the application of the changes in CD45+EpCAM+ cell ratio of PBMCs combined with the changes in CEA and CYFRA21-1serum level and other diagnostic methods may be useful for an early diagnosis of lung cancer. This evidence concerns the gene PTPRC and lung carcinoma.